


Healthcare News Roundup: Drug Delivery
HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
HSMN NewsFeed - 26 Mar 2014
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
